Freenome lands $270m Series C
South San Francisco-based Freenome, a provider of a multiomics platform for early cancer detection, has raised $270 million in Series C funding.
26 August 2020•1 min read
South San Francisco-based Freenome, a provider of a multiomics platform for early cancer detection, has raised $270 million in Series C funding.